Huntington National Bank’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.2K | Buy |
1,588
+202
| +15% | +$1.94K | ﹤0.01% | 1653 |
|
|
2025
Q1 | $8.69K | Sell |
1,386
-111
| -7% | -$696 | ﹤0.01% | 1800 |
|
|
2024
Q4 | $12.2K | Buy |
1,497
+26
| +2% | +$211 | ﹤0.01% | 1707 |
|
|
2024
Q3 | $26.6K | Buy |
1,471
+564
| +62% | +$10.2K | ﹤0.01% | 1418 |
|
|
2024
Q2 | $9.34K | Sell |
907
-71
| -7% | -$731 | ﹤0.01% | 1717 |
|
|
2024
Q1 | $10.4K | Buy |
978
+18
| +2% | +$191 | ﹤0.01% | 1664 |
|
|
2023
Q4 | $8.77K | Sell |
960
-91
| -9% | -$831 | ﹤0.01% | 1700 |
|
|
2023
Q3 | $10.9K | Sell |
1,051
-18
| -2% | -$187 | ﹤0.01% | 1536 |
|
|
2023
Q2 | $15.3K | Buy |
1,069
+104
| +11% | +$1.49K | ﹤0.01% | 1442 |
|
|
2023
Q1 | $6.89K | Buy |
965
+40
| +4% | +$286 | ﹤0.01% | 1641 |
|
|
2022
Q4 | $10.4K | Sell |
925
-4
| -0.4% | -$45 | ﹤0.01% | 1477 |
|
|
2022
Q3 | $10K | Sell |
929
-110
| -11% | -$1.18K | ﹤0.01% | 1534 |
|
|
2022
Q2 | $9K | Buy |
1,039
+919
| +766% | +$7.96K | ﹤0.01% | 1607 |
|
|
2022
Q1 | $2K | Sell |
120
-5
| -4% | -$83 | ﹤0.01% | 1917 |
|
|
2021
Q4 | $2K | Buy |
+125
| New | +$2K | ﹤0.01% | 1902 |
|